 |
|
|
REFERENCES
1.
Halpern NA, Bettes L, Greenstein R: Federal and
nationwide intensive care units and healthcare costs: 1986–1992. Crit Care
Med 22:2001–2007, 1994.
2.
Angus DC, Kelley MA, Schmitz RJ, et al: Caring
for the critically ill patient. Current and projected workforce requirements for
care of the critically ill and patients with pulmonary disease: Can we meet the
requirements of an aging population? JAMA 284:2762–2770, 2000.
3.
Pronovost PJ, Angus DC, Dorman T, et al: Physician
staffing patterns and clinical outcomes in critically ill patients: A systematic
review. JAMA 288:2151–2162, 2002.
4.
Carson SS, Stocking C, Podsadecki T, et al: Effects
of organizational change in the medical intensive care unit of a teaching hospital.
JAMA 276:322–328, 1996.
5.
Ghorra S, Reinert SE, Cioffi W, et al: Analysis
of the effect of conversion from open to closed surgical intensive care unit. Ann
Surg 229:163–171, 1999.
6.
Pronovost PJ, Jenckes MW, Dorman T, et al: Organizational
characteristics of intensive care units related to outcomes of abdominal aortic surgery.
JAMA 281:1310–1317, 1999.
7.
Gropper M, Matthay MA: Look before you leap: How
do intensivists improve care for critically ill patients? Am J Med 116:206–207,
2004.
8.
Guidelines for the definition of an intensivist
and the practice of critical care medicine. Guidelines Committee, Society of Critical
Care Medicine. Crit Care Med 20:540–542, 1992.
9.
Ventilation with lower tidal volumes as compared
with traditional tidal volumes for acute lung injury and the acute respiratory distress
syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342:1301–1308,
2000.
10.
Kollef MH, Horst HM, Prang L, Brock WA: Reducing
the duration of mechanical ventilation: Three examples of change in the intensive
care unit. New Horiz 6:52–60, 1998.
11.
Holcomb BW, Wheeler AP, Ely EW: New ways to reduce
unnecessary variation and improve outcomes in the intensive care unit. Curr Opin
Crit Care 7:304–311, 2001.
12.
MacIntyre NR, Cook DJ, Ely EW Jr, et al: Evidence-based
guidelines for weaning and discontinuing ventilatory support: A collective task
force facilitated by the American College of Chest Physicians; the American Association
for Respiratory Care; and the American College of Critical Care Medicine. Chest
120(Suppl):375S–395S, 2001.
13.
Thorens JB, Kaelin RM, Jolliet P, Chevrolet JC:
Influence of the quality of nursing on the duration of weaning from mechanical ventilation
in patients with chronic obstructive pulmonary disease. Crit Care Med 23:1807–1815,
1995.
14.
Ashbaugh DG, Bigelow DB, Petty TL, Levine BE:
Acute respiratory distress in adults. Lancet 2:319–323, 1967.
15.
Bernard GR, Artigas A, Brigham KL, et al: The
American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant
outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824,
1994.
16.
Luhr OR, Antonsen K, Karlsson M, et al: Incidence
and mortality after acute respiratory failure and acute respiratory distress syndrome
in Sweden, Denmark, and Iceland. The ARF Study Group. Am J Respir Crit Care Med
159:1849–1861, 1999.
17.
Brower RG, Ware LB, Berthiaume Y, Matthay MA:
Treatment of ARDS. Chest 120:1347–1367, 2001.
18.
Suchyta MR, Clemmer TP, Elliott CG, et al: The
adult respiratory distress syndrome: A report of survival and modifying factors.
Chest 101:1074–1079, 1992.
19.
Montgomery AB, Stager MA, Carrico CJ, Hudson LD:
Causes of mortality in patients with the adult respiratory distress syndrome. Am
Rev Respir Dis 132:485–489, 1985.
20.
Milberg JA, Davis DR, Steinberg KP, Hudson LD:
Improved survival of patients with acute respiratory distress syndrome (ARDS):
1983–1993. JAMA 273:306–309, 1995.
21.
Tsuno K, Miura K, Takeya M, et al: Histopathologic
pulmonary changes from mechanical ventilation at high peak airway pressures. Am
Rev Respir Dis 143:1115–1120, 1991.
22.
Kolobow T, Moretti MP, Fumagalli R, et al: Severe
impairment in lung function induced by high peak airway pressure during mechanical
ventilation. An experimental study. Am Rev Respir Dis 135:312–315, 1987.
23.
Slutsky AS, Tremblay LN: Multiple system organ
failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care
Med 157:1721–1725, 1998.
24.
Hickling KG, Henderson SJ, Jackson R: Low mortality
associated with low volume pressure limited ventilation with permissive hypercapnia
in severe adult respiratory distress syndrome. Intensive Care Med 16:372–377,
1990.
25.
Hickling KG, Walsh J, Henderson S, Jackson R:
Low mortality rate in adult respiratory distress syndrome using low-volume, pressure-limited
ventilation with permissive hypercapnia: A prospective study. Crit Care Med 22:1568–1578,
1994.
26.
Amato MB, Barbas CS, Medeiros DM, et al: Effect
of a protective-ventilation strategy on mortality in the acute respiratory distress
syndrome. N Engl J Med 338:347–354, 1998.
27.
Brochard L, Roudot-Thoraval F, Roupie E, et al:
Tidal volume reduction for prevention of ventilator-induced lung injury in acute
respiratory distress syndrome. The Multicenter Trial Group on Tidal Volume reduction
in ARDS. Am J Respir Crit Care Med 158:1831–1838, 1998.
28.
Stewart TE, Meade MO, Cook DJ, et al: Evaluation
of a ventilation strategy to prevent barotrauma in patients at high risk for acute
respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy
Group. N Engl J Med 338:355–361, 1998.
29.
Brower RG, Shanholtz CB, Fessler HE, et al: Prospective,
randomized, controlled clinical trial comparing traditional versus reduced tidal
volume ventilation in acute respiratory distress syndrome patients. Crit Care Med
27:1492–1498, 1999.
30.
Ware LB, Matthay MA: The acute respiratory distress
syndrome. N Engl J Med 342:1334–1349, 2000.
31.
Eisner MD, Thompson T, Hudson LD, et al: Efficacy
of low tidal volume ventilation in patients with different clinical risk factors
for acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit
Care Med 164:231–236, 2001.
32.
Ely EW, Baker AM, Evans GW, Haponik EF: The distribution
of costs of care in mechanically ventilated patients with chronic obstructive pulmonary
disease. Crit Care Med 28:408–413, 2000.
33.
Epstein SK, Ciubotaru RL, Wong JB: Effect of failed
extubation on the outcome of mechanical ventilation. Chest 112:186–192, 1997.
34.
Esteban A, Alia I, Ibanez J, et al: Modes of mechanical
ventilation and weaning: A national survey of Spanish hospitals. The Spanish Lung
Failure Collaborative Group. Chest 106:1188–1193, 1994.
35.
Venus B, Smith RA, Mathru M: National survey of
methods and criteria used for weaning from mechanical ventilation. Crit Care Med
15:530–533, 1987.
36.
Luce JM, Pierson DJ, Hudson LD: Intermittent mandatory
ventilation. Chest 79:678–685, 1981.
37.
Nathan SD, Ishaaya AM, Koerner SK, Belman MJ:
Prediction of minimal pressure support during weaning from mechanical ventilation.
Chest 103:1215–1219, 1993.
38.
Esteban A, Frutos F, Tobin MJ, et al: A comparison
of four methods of weaning patients from mechanical ventilation. Spanish Lung Failure
Collaborative Group. N Engl J Med 332:345–350, 1995.
39.
Brochard L, Rauss A, Benito S, et al: Comparison
of three methods of gradual withdrawal from ventilatory support during weaning from
mechanical ventilation. Am J Respir Crit Care Med 150:896–903, 1994.
40.
Mador MJ: Weaning parameters. Are they clinically
useful? Chest 102:1642–1643, 1992.
41.
Stoller JK, Mascha EJ, Kester L, Haney D: Randomized
controlled trial of physician-directed versus respiratory therapy consult service-directed
respiratory care to adult non-ICU inpatients. Am J Respir Crit Care Med 158:1068–1075,
1998.
42.
Ely EW, Baker AM, Dunagan DP, et al: Effect on
the duration of mechanical ventilation of identifying patients capable of breathing
spontaneously. N Engl J Med 335:1864–1869, 1996.
43.
Kollef MH, Shapiro SD, Silver P, et al: A randomized,
controlled trial of protocol-directed versus physician-directed weaning from mechanical
ventilation. Crit Care Med 25:567–574, 1997.
44.
Marelich GP, Murin S, Battistella F, et al: Protocol
weaning of mechanical ventilation in medical and surgical patients by respiratory
care practitioners and nurses: Effect on weaning time and incidence of ventilator-associated
pneumonia. Chest 118:459–467, 2000.
45.
Ely EW, Baker AM, Evans GW, Haponik EF: The prognostic
significance of passing a daily screen of weaning parameters. Intensive Care Med
25:581–587, 1999.
46.
Krieger BP, Ershowsky PF, Becker DA, Gazeroglu
HB: Evaluation of conventional criteria for predicting successful weaning from mechanical
ventilatory support in elderly patients. Crit Care Med 17:858–861, 1989.
47.
Esteban A, Anzueto A, Alia I, et al: How is mechanical
ventilation employed in the intensive care unit? An international utilization review.
Am J Respir Crit Care Med 161:1450–1458, 2000.
48.
Angus DC, Linde-Zwirble WT, Lidicker J, et al:
Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome,
and associated costs of care. Crit Care Med 29:1303–1310, 2001.
49.
Rangel-Frausto MS, Pittet D, Costigan M, et al:
The natural history of the systemic inflammatory response syndrome (SIRS): A prospective
study. JAMA 273:117–123, 1995.
50.
Centers for Disease Control: Increase in National
Hospital Discharge Survey rates for septicemia—United States, 1979–1987.
JAMA 263:937–938, 1990.
51.
Rivers E, Nguyen B, Havstad S, et al: Early goal-directed
therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377,
2001.
52.
Annane D, Sebille V, Charpentier C, et al: Effect
of treatment with low doses of hydrocortisone and fludrocortisone on mortality in
patients with septic shock. JAMA 288:862–871, 2002.
53.
Bernard GR, Vincent JL, Laterre PF, et al: Efficacy
and safety of recombinant human activated protein C for severe sepsis. N Engl J
Med 344:699–709, 2001.
54.
Beal AL, Cerra FB: Multiple organ failure syndrome
in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 271:226–233,
1994.
55.
Gattinoni L, Brazzi L, Pelosi P, et al: A trial
of goal-oriented hemodynamic therapy in critically ill patients. SVO2
Collaborative Group. N Engl J Med 333:1025–1032, 1995.
56.
Hayes MA, Timmins AC, Yau EH, et al: Elevation
of systemic oxygen delivery in the treatment of critically ill patients. N Engl
J Med 330:1717–1722, 1994.
57.
Boyd O, Grounds RM, Bennett ED: A randomized clinical
trial of the effect of deliberate perioperative increase of oxygen delivery on mortality
in high-risk surgical patients. JAMA 270:2699–2707, 1993.
58.
Connors AF Jr, Speroff T, Dawson NV, et al: The
effectiveness of right heart catheterization in the initial care of critically ill
patients. SUPPORT Investigators. JAMA 276:889–897, 1996.
59.
Richard C, Warszawski J, Anguel N, et al: Early
use of the pulmonary artery catheter and outcomes in patients with shock and acute
respiratory distress syndrome: A randomized controlled trial. JAMA 290:2713–2720,
2003.
60.
Sandham JD, Hull RD, Brant RF, et al: A randomized,
controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.
N Engl J Med 348:5–14, 2003.
61.
Yu DT, Platt R, Lanken PN, et al: Relationship
of pulmonary artery catheter use to mortality and resource utilization in patients
with severe sepsis. Crit Care Med 31:2734–2741, 2003.
62.
Network AC: Fluids and Catheters Treatment Trial,
National Institutes of Health; unpublished data.
63.
Intensive Care National Audit and Research (ICNANR)
Centre: Pulmonary Artery Catheters in Patient Management in Intensive Care, National
Health Service, UK, unpublished data.
64.
Lefering R, Neugebauer EA: Steroid controversy
in sepsis and septic shock: A meta-analysis. Crit Care Med 23:1294–1303,
1995.
65.
Cronin L, Cook DJ, Carlet J, et al: Corticosteroid
treatment for sepsis: A critical appraisal and meta-analysis of the literature.
Crit Care Med 23:1430–1439, 1995.
66.
Riedemann NC, Guo RF, Ward PA: Novel strategies
for the treatment of sepsis. Nat Med 9:517–524, 2003.
67.
Hotchkiss RS, Karl IE: The pathophysiology and
treatment of sepsis. N Engl J Med 348:138–150, 2003.
68.
Rothwell PM, Udwadia ZF, Lawler PG: Cortisol response
to corticotropin and survival in septic shock. Lancet 337:582–583, 1991.
69.
Molijn GJ, Spek JJ, van Uffelen JC, et al: Differential
adaptation of glucocorticoid sensitivity of peripheral blood mononuclear leukocytes
in patients with sepsis or septic shock. J Clin Endocrinol Metab 80:1799–1803,
1995.
70.
Annane D, Bellissant E, Sebille V, et al: Impaired
pressor sensitivity to noradrenaline in septic shock patients with and without impaired
adrenal function reserve. Br J Clin Pharmacol 46:589–597, 1998.
71.
Bellissant E, Annane D: Effect of hydrocortisone
on phenylephrine—Mean arterial pressure dose-response relationship in septic
shock. Clin Pharmacol Ther 68:293–303, 2000.
72.
Annane D, Sebille V, Troche G, et al: A 3-level
prognostic classification in septic shock based on cortisol levels and cortisol response
to corticotropin. JAMA 283:1038–1045, 2000.
73.
Bollaert PE, Charpentier C, Levy B, et al: Reversal
of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med
26:645–650, 1998.
74.
Briegel J, Forst H, Haller M, et al: Stress doses
of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized,
double-blind, single-center study. Crit Care Med 27:723–732, 1999.
75.
Abraham E, Evans T: Corticosteroids and septic
shock. JAMA 288:886–887, 2002.
76.
Levi M, Ten Cate H: Disseminated intravascular
coagulation. N Engl J Med 341:586–592, 1999.
77.
Vervloet MG, Thijs LG, Hack CE: Derangements of
coagulation and fibrinolysis in critically ill patients with sepsis and septic shock.
Semin Thromb Hemost 24:33–44, 1998.
78.
Powars DR, Rogers ZR, Patch MJ, et al: Purpura
fulminans in meningococcemia: Association with acquired deficiencies of proteins
C and S. N Engl J Med 317:571–572, 1987.
79.
Esmon CT: The protein C anticoagulant pathway.
Arterioscler Thromb 12:135–145, 1992.
80.
Manns BJ, Lee H, Doig CJ, et al: An economic evaluation
of activated protein C treatment for severe sepsis. N Engl J Med 347:993–1000,
2002.
81.
Richards MJ, Edwards JR, Culver DH, Gaynes RP:
Nosocomial infections in medical intensive care units in the United States. National
Nosocomial Infections Surveillance System. Crit Care Med 27:887–892, 1999.
82.
Pingleton SK, Fagon JY, Leeper KV Jr: Patient
selection for clinical investigation of ventilator-associated pneumonia: Criteria
for evaluating diagnostic techniques. Chest 102:553S–556S, 1992.
83.
Ibrahim EH, Tracy L, Hill C, et al: The occurrence
of ventilator-associated pneumonia in a community hospital: Risk factors and clinical
outcomes. Chest 120:555–561, 2001.
84.
Fagon JY, Chastre J, Hance AJ, et al: Nosocomial
pneumonia in ventilated patients: A cohort study evaluating attributable mortality
and hospital stay. Am J Med 94:281–288, 1993.
85.
Chastre J, Fagon JY: Ventilator-associated pneumonia.
Am J Respir Crit Care Med 165:867–903, 2002.
86.
Baker AM, Meredith JW, Haponik EF: Pneumonia in
intubated trauma patients. Microbiology and outcomes. Am J Respir Crit Care Med
153:343–349, 1996.
87.
George DL, Falk PS, Wunderink RG, et al: Epidemiology
of ventilator-acquired pneumonia based on protected bronchoscopic sampling. Am J
Respir Crit Care Med 158:1839–1847, 1998.
88.
Heyland DK, Cook DJ, Griffith L, et al: The attributable
morbidity and mortality of ventilator-associated pneumonia in the critically ill
patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 159:1249–1256,
1999.
89.
Craven DE, Steger KA: Nosocomial pneumonia in
mechanically ventilated adult patients: Epidemiology and prevention in 1996. Semin
Respir Infect 11:32–53, 1996.
90.
Hospital-acquired pneumonia in adults: Diagnosis,
assessment of severity, initial antimicrobial therapy, and preventive strategies.
A consensus statement, American Thoracic Society, November 1995. Am J Respir Crit
Care Med 153:1711–1725, 1996.
91.
Fagon JY, Chastre J, Wolff M, et al: Invasive
and noninvasive strategies for management of suspected ventilator-associated pneumonia:
A randomized trial. Ann Intern Med 132:621–630, 2000.
92.
Papazian L, Thomas P, Garbe L, et al: Bronchoscopic
or blind sampling techniques for the diagnosis of ventilator-associated pneumonia.
Am J Respir Crit Care Med 152:1982–1991, 1995.
93.
Bregeon F, Papazian L, Thomas P, et al: Diagnostic
accuracy of protected catheter sampling in ventilator-associated bacterial pneumonia.
Eur Respir J 16:969–975, 2000.
94.
Cook DJ, Reeve BK, Guyatt GH, et al: Stress ulcer
prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA
275:308–314, 1996.
95.
Tryba M: Prophylaxis of stress ulcer bleeding:
A meta-analysis. J Clin Gastroenterol 13(Suppl 2):S44–S55, 1991.
96.
Cook DJ, Laine LA, Guyatt GH, Raffin TA: Nosocomial
pneumonia and the role of gastric pH: A meta-analysis. Chest 100:7–13, 1991.
97.
Drakulovic MB, Torres A, Bauer TT, et al: Supine
body position as a risk factor for nosocomial pneumonia in mechanically ventilated
patients: A randomised trial. Lancet 354:1851–1858, 1999.
98.
Mahul P, Auboyer C, Jospe R, et al: Prevention
of nosocomial pneumonia in intubated patients: Respective role of mechanical subglottic
secretions drainage and stress ulcer prophylaxis. Intensive Care Med 18:20–25,
1992.
99.
Valles J, Artigas A, Rello J, et al: Continuous
aspiration of subglottic secretions in preventing ventilator-associated pneumonia.
Ann Intern Med 122:179–186, 1995.
100.
Kollef MH, Skubas NJ, Sundt TM: A randomized
clinical trial of continuous aspiration of subglottic secretions in cardiac surgery
patients. Chest 116:1339–1346, 1999.
101.
Collard HR, Saint S, Matthay MA: Prevention of
ventilator-associated pneumonia: An evidence-based systematic review. Ann Intern
Med 138:494–501, 2003.
102.
Raad I: Intravascular-catheter-related infections.
Lancet 351:893–898, 1998.
103.
Merrer J, De Jonghe B, Golliot F, et al: Complications
of femoral and subclavian venous catheterization in critically ill patients: A randomized
controlled trial. JAMA 286:700–707, 2001.
104.
Veenstra DL, Saint S, Saha S, et al: Efficacy
of antiseptic-impregnated central venous catheters in preventing catheter-related
bloodstream infection: A meta-analysis. JAMA 281:261–267, 1999.
105.
Raad I, Darouiche R, Dupuis J, et al: Central
venous catheters coated with minocycline and rifampin for the prevention of catheter-related
colonization and bloodstream infections. A randomized, double-blind trial. The
Texas Medical Center Catheter Study Group. Ann Intern Med 127:267–274, 1997.
106.
Collignon PJ: Intravascular catheter associated
sepsis: A common problem. The Australian Study on Intravascular Catheter Associated
Sepsis. Med J Aust 161:374–378, 1994.
107.
Heiselman D: Nosocomial bloodstream infections
in the critically ill. JAMA 272:1819–1820, 1994.
108.
Arnow PM, Quimosing EM, Beach M: Consequences
of intravascular catheter sepsis. Clin Infect Dis 16:778–784, 1993.
109.
Maki DG, Stolz SM, Wheeler S, Mermel LA: Prevention
of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated
catheter: A randomized, controlled trial. Ann Intern Med 127:257–266, 1997.
110.
Veenstra DL, Saint S, Sullivan SD: Cost-effectiveness
of antiseptic-impregnated central venous catheters for the prevention of catheter-related
bloodstream infection. JAMA 282:554–560, 1999.
111.
Darouiche RO, Raad II, Heard SO, et al: A comparison
of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
N Engl J Med 340:1–8, 1999.
112.
McGee DC, Gould MK: Preventing complications
of central venous catheterization. N Engl J Med 348:1123–1133, 2003.
113.
Raad II, Hohn DC, Gilbreath BJ, et al: Prevention
of central venous catheter-related infections by using maximal sterile barrier precautions
during insertion. Infect Control Hosp Epidemiol 15:231–238, 1994.
114.
Pearson ML: Guideline for prevention of intravascular
device-related infections. Part I. Intravascular device-related infections: An
overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect
Control 24:262–277, 1996.
115.
Mimoz O, Pieroni L, Lawrence C, et al: Prospective,
randomized trial of two antiseptic solutions for prevention of central venous or
arterial catheter colonization and infection in intensive care unit patients. Crit
Care Med 24:1818–1823, 1996.
116.
Randolph AG, Cook DJ, Gonzales CA, Pribble CG:
Ultrasound guidance for placement of central venous catheters: A meta-analysis
of the literature. Crit Care Med 24:2053–2058, 1996.
117.
Lefrant JY, Cuvillon P, Benezet JF, et al: Pulsed
Doppler ultrasonography guidance for catheterization of the subclavian vein: A randomized
study. Anesthesiology 88:1195–1201, 1998.
118.
Shojania KG: Making Health Care Safer: A Critical
Analysis of Patient Safety Practices. Rockville, MD, Agency for Healthcare Research
and Quality, Department of Health and Human Services, 2001.
119.
Maki DG, Stolz SS, Wheeler S, Mermel LA: A prospective,
randomized trial of gauze and two polyurethane dressings for site care of pulmonary
artery catheters: Implications for catheter management. Crit Care Med 22:1729–1737,
1994.
120.
Raad I, Umphrey J, Khan A, et al: The duration
of placement as a predictor of peripheral and pulmonary arterial catheter infections.
J Hosp Infect 23:17–26, 1993.
121.
Cook D, Randolph A, Kernerman P, et al: Central
venous catheter replacement strategies: A systematic review of the literature.
Crit Care Med 25:1417–1424, 1997.
122.
Cobb DK, High KP, Sawyer RG, et al: A controlled
trial of scheduled replacement of central venous and pulmonary-artery catheters.
N Engl J Med 327:1062–1068, 1992.
123.
Novaes MA, Knobel E, Bork AM, et al: Stressors
in ICU: Perception of the patient, relatives and health care team. Intensive Care
Med 25:1421–1426, 1999.
124.
Puntillo KA: Pain experiences of intensive care
unit patients. Heart Lung 19:526–533, 1990.
125.
Simini B: Patients' perceptions of intensive
care. Lancet 354:571–572, 1999.
126.
Stein-Parbury J, McKinley S: Patients' experiences
of being in an intensive care unit: A select literature review. Am J Crit Care
9:20–27, 2000.
127.
Schelling G, Stoll C, Haller M, et al: Health-related
quality of life and posttraumatic stress disorder in survivors of the acute respiratory
distress syndrome. Crit Care Med 26:651–659, 1998.
128.
Kress JP, Pohlman AS, O'Connor MF, Hall JB: Daily
interruption of sedative infusions in critically ill patients undergoing mechanical
ventilation. N Engl J Med 342:1471–1477, 2000.
129.
Ramsay MA, Savege TM, Simpson BR, Goodwin R:
Controlled sedation with alphaxalone-alphadolone. BMJ 2:656–659, 1974.
130.
Hansen-Flaschen J, Cowen J, Polomano RC: Beyond
the Ramsay scale: Need for a validated measure of sedating drug efficacy in the
intensive care unit. Crit Care Med 22:732–733, 1994.
131.
Riker RR, Fraser GL, Cox PM: Continuous infusion
of haloperidol controls agitation in critically ill patients. Crit Care Med 22:433–440,
1994.
132.
Riker RR, Picard JT, Fraser GL: Prospective evaluation
of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med
27:1325–1329, 1999.
133.
Clemmer TP, Wallace JC, Spuhler VJ, et al: Origins
of the Motor Activity Assessment Scale score: A multi-institutional process. Crit
Care Med 28:3124, 2000.
134.
Devlin JW, Boleski G, Mlynarek M, et al: Motor
Activity Assessment Scale: A valid and reliable sedation scale for use with mechanically
ventilated patients in an adult surgical intensive care unit. Crit Care Med 27:1271–1275,
1999.
135.
Devlin JW, Fraser GL, Kanji S, Riker RR: Sedation
assessment in critically ill adults. Ann Pharmacother 35:1624–1632, 2001.
136.
Brook AD, Ahrens TS, Schaiff R, et al: Effect
of a nursing-implemented sedation protocol on the duration of mechanical ventilation.
Crit Care Med 27:2609–2615, 1999.
137.
Mascia MF, Koch M, Medicis JJ: Pharmacoeconomic
impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular
blockade in critical care. Crit Care Med 28:2300–2306, 2000.
138.
Jacobi J, Fraser G, Coursin D, Riker R, et al:
Clinical practice guidelines for the sustained use of sedatives and analgesics in
the critically ill adult. Crit Care Med 30:119–141, 2002.
139.
Meszaros K, Lang CH, Bagby GJ, Spitzer JJ: Contribution
of different organs to increased glucose consumption after endotoxin administration.
J Biol Chem 262:10965–10970, 1987.
140.
Cerra FB: Hypermetabolism, organ failure, and
metabolic support. Surgery 101:1–14, 1987.
141.
Wolfe RR, Herndon DN, Jahoor F, et al: Effect
of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J
Med 317:403–408, 1987.
142.
Wolfe RR, Jahoor F, Herndon DN, Miyoshi H: Isotopic
evaluation of the metabolism of pyruvate and related substrates in normal adult volunteers
and severely burned children: Effect of dichloroacetate and glucose infusion. Surgery
110:54–67, 1991.
143.
Lang CH, Dobrescu C, Meszaros K: Insulin-mediated
glucose uptake by individual tissues during sepsis. Metabolism 39:1096–1107,
1990.
144.
Mizock BA: Alterations in carbohydrate metabolism
during stress: A review of the literature. Am J Med 98:75–84, 1995.
145.
McCowen KC, Malhotra A, Bistrian BR: Stress-induced
hyperglycemia. Crit Care Clin 17:107–124, 2001.
146.
Perner A, Nielsen SE, Rask-Madsen J: High glucose
impairs superoxide production from isolated blood neutrophils. Intensive Care Med
29:642–645, 2003.
147.
Fietsam R Jr, Bassett J, Glover JL: Complications
of coronary artery surgery in diabetic patients. Am Surg 57:551–557, 1991.
148.
O'Neill PA, Davies I, Fullerton KJ, Bennett D:
Stress hormone and blood glucose response following acute stroke in the elderly.
Stroke 22:842–847, 1991.
149.
Scott JF, Robinson GM, French JM, et al: Glucose
potassium insulin infusions in the treatment of acute stroke patients with mild to
moderate hyperglycemia: The Glucose Insulin in Stroke Trial (GIST). Stroke 30:793–799,
1999.
150.
Malmberg K: Prospective randomised study of intensive
insulin treatment on long term survival after acute myocardial infarction in patients
with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute
Myocardial Infarction) Study Group. BMJ 314:1512–1515, 1997.
